Clinical
India Touts A Safe Haven For Investors But Says No To Big Pharma
India’s Supreme Court rejected Novartis’ patent application for the cancer drug Glivec yesterday. A victory for the Indian drug industry, but the result may have repercussions on India’s attempts to attract foreign investment